The Only Drug Developed for COVID-19 Received Approval for Use

After vaccines, our greatest hope for COVID-19 was that a COVID-19 drug would be produced and approved for use. The closest drug to receive this approval was the drug produced by Roche, which was also recommended by the World Health Organization.

European Medicines Agency (EMA), today a Swiss pharmaceutical company Approved the COVID-19 drug produced by Roche. The price of the drug, which ensures that drug treatment is clearly included in the epidemic, is a bit salty, at least for now.

There may be alternatives next year

Roche’s coronavirus drug, RoActemra, received approval for use today as the only drug developed to treat COVID-19 patients. This step is very important for vehicles other than vaccines to support the war against the pandemic. For If the production of the drug increases or if different alternatives are produced, The price may vary in a way that many people can reach.

However, for now, the price has a price that only those who have a severe illness will prefer. We do not know how many people buy this drug in Turkey, especially considering the current state of the euro exchange rate. The planned sale price of the drug, which is sold under the names RoActemra and Actemra and whose active ingredient is ‘tocilizumab’, is currently 800 euro per injection. The drug significantly reduces the rate of death and admission to intensive care. Experts say that with the release of new drugs in 2022, we will have very serious weapons against COVID-19 and that the death rates will decrease to the lowest level possible with the decrease in prices.